Boston Scientific Infinion CX Recall: What the Class I Notice Means for SCS Patients

Last reviewed: September 22, 2026

The new FDA recall notice for Boston Scientific's Infinion CX lead is narrow, but it is still worth reading carefully if you live with a spinal cord stimulator. The recall is not a blanket instruction for implanted patients to rush into surgery. It is a Class I removal of unused lead kits that were still in hospitals, clinics, or distribution.

That distinction matters. The same FDA notice also says the lead body may experience mechanical stress at the anchor site, which can lead to high impedance readings, lead fractures, inadequate stimulation, and sometimes another procedure, including lead explant and replacement. For someone already dealing with shocks, burning, loss of therapy, or a revision discussion, those words may sound familiar.

Our main litigation page is here: Boston Scientific Spinal Cord Stimulator Lawsuit. We also recently wrote about direct filing and the records we would gather first.

What the FDA recall actually covers

The FDA's recall page identifies two Infinion CX Lead Kit models: SC-2317-50 and SC-2317-70. Boston Scientific sent customers a removal letter on June 17, 2026. The FDA says the recall involves removing unused devices from where they are used or sold, and that it does not affect devices that have already been implanted.

The recall database entry is more specific. It lists Recall Number Z-2879-2026, Recall Event ID 98974, PMA number P030017, and 1,079 total units in commerce. The FDA-determined cause is listed as "Device Design." The manufacturer's stated reason is that the lead body may be exposed to stress at the anchor site, causing high impedance measurements or lead fractures.

The public FDA notice also reports 1,081 serious injuries and no deaths associated with the issue as of May 27, 2026. Those numbers should not be blended together. The 1,079 figure refers to unused lead kits in commerce. The 1,081 figure refers to reported serious injuries associated with the issue.

Why this matters inside MDL 3181

MDL 3181 is the federal Boston Scientific spinal cord stimulator litigation in the Central District of California before Judge Josephine L. Staton. The JPML created the MDL on June 5, 2026 and declined, at that time, to create one industry-wide spinal cord stimulator MDL covering every manufacturer.

The transfer order describes allegations involving unsatisfactory pain relief, shocking, burning, lead migration, autonomic dysfunction, and neurological injuries after implantation. The new Infinion CX recall does not prove anyone's individual case. It also does not decide whether Boston Scientific is legally responsible for a patient's injury.

But it is a fresh regulatory fact about a Boston Scientific SCS component, and it uses concrete failure language: anchor-site stress, high impedance, lead fracture, inadequate stimulation, and possible explant or replacement. Those are the kinds of details a reviewer will want to compare against the medical record.

Records to pull if Infinion CX is mentioned in your chart

If you are unsure which Boston Scientific lead was implanted, start with the paperwork rather than memory. Hospitals often scan device stickers into the operative report. Pain clinics may also have interrogation notes or programming notes that name the generator and lead models.

Helpful records may include:

• the implant card or a photo of it;
• the operative report from the original SCS implant;
• the device sticker sheet, if your hospital can provide it;
• programming or interrogation notes showing impedance readings;
• notes about loss of stimulation, inadequate stimulation, shocking, burning, or sudden therapy changes;
• imaging or surgical notes mentioning lead fracture or lead migration;
• records of reprogramming attempts; and
• revision, replacement, or explant records if another procedure was recommended or performed.

Do not stop or change spinal cord stimulator use because of an article online. The FDA notice says no additional patient monitoring beyond routine clinical follow-up is recommended for implanted patients. If your device is not working, or if it is causing new symptoms, talk with the physician or clinic that manages it.

A careful way to read the recall

For patients, the important question is not just, "Was there a recall?" It is, "Does my own record show a device problem that lines up with the failure described?"

A person with an unused lead kit on a hospital shelf is different from a patient with an implanted Infinion CX lead and a history of high impedance readings. A patient with a different Boston Scientific lead may be on a different factual track. A patient with Abbott, Medtronic, or Nevro hardware may need a separate review because those claims are not automatically part of MDL 3181.

That is why model identification is the first practical step. Once the device is identified, the next step is lining up the symptom timeline with the clinic records: when stimulation changed, when reprogramming happened, what the doctor documented, and whether another procedure was discussed.

FAQ

Does the Infinion CX recall mean implanted patients need the lead removed?

No. The FDA says the action does not affect devices that have already been implanted and that no additional patient monitoring beyond routine clinical follow-up is recommended. Any decision about removal or replacement is a medical decision for the treating team.

What symptoms or events may be relevant to a legal review?

A review may look at loss of stimulation, inadequate stimulation, high impedance readings, lead fracture, lead migration, painful shocks, burning, revision surgery, replacement, or explant. The records matter more than a general description.

Is this the same thing as a settlement?

No. A recall notice is not a settlement, verdict, or admission that Boston Scientific is liable in a specific case.

Sources

• FDA, Spinal Cord Stimulator Recall: Boston Scientific Removes Infinion CX Lead: https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/spinal-cord-stimulator-recall-boston-scientific-removes-infinion-cx-lead
• FDA Medical Device Recall database, Recall Z-2879-2026 / Event ID 98974: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=220311
• JPML Transfer Order, MDL No. 3181, June 5, 2026: https://www.jpml.uscourts.gov/sites/jpml/files/MDL-3181-Transfer_Order-5-26.pdf
• AboutLawsuits, direct-filing order coverage, August 31, 2026: https://www.aboutlawsuits.com/spinal-cord-stimulator-lawsuit/judge-back-stimulator-lawsuits-boston-scientific-directly-filed-mdl/
• MedTech Dive, Boston Scientific recall coverage, September 2026: https://www.medtechdive.com/news/boston-scientific-recall-of-spinal-cord-stimulator-leads-tied-to-more-than/829699/

Attorney advertising / informational notice

This article is attorney advertising and is for general information only. It is not medical advice and does not create an attorney-client relationship. Prior results do not guarantee a similar outcome. If you have a spinal cord stimulator and new symptoms, speak with your medical provider about what to do next.

Claims reviewed by Baker Legal Team
Robert B. Baker, Esq., B.C.S. — Board-Certified Civil Trial Lawyer. 30+ years of trial experience, more than $400 million recovered for clients. About Robert Baker →